Beranda › Kanker Paru Non-Sel Kecil › Washington › Tacoma
Uji klinis Kanker Paru Non-Sel Kecil di Tacoma, WA
20 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Tacoma (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Menerima pesertaFase 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · 26 mi jauhnya
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Menerima pesertaFase 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · 8 mi jauhnya
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · 8 mi jauhnya
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- American Oncology Network Vista Oncology Division-West office, Olympia · 26 mi jauhnya
- American Oncology Network Vista Oncology Division-East office, Olympia · 26 mi jauhnya
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Menerima pesertaFase 3
- Vista Oncology Inc PS, Olympia · 26 mi jauhnya
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Vista Oncology, Olympia · 26 mi jauhnya
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Menerima pesertaFase 3
- American Oncology Network Vista Oncology Division-West office, Olympia · 26 mi jauhnya
- American Oncology Network Vista Oncology Division-East office, Olympia · 26 mi jauhnya
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
Menerima pesertaStudi observasional
- Northwest Medical Specialties (NWMS), Tacoma
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Menerima pesertaFase 3
- Research Site, Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Menerima pesertaFase 3
- Local Institution - 0499, Lacey · 23 mi jauhnya
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Research Site, Tacoma
- Research Site, Olympia · 26 mi jauhnya
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · 26 mi jauhnya
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Menerima pesertaFase 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Menerima pesertaFase 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · 8 mi jauhnya
- dan 3 lainnya
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Menerima pesertaFase 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · 8 mi jauhnya
- MultiCare Regional Cancer Center, Puyallup · 8 mi jauhnya
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 2
- USA09-0, Puyallup · 8 mi jauhnya
BostonGene and Exigent Genomic INsight Study
Menerima pesertaStudi observasional
- Northwest Medical Specialities, Puyallup · 8 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Tacoma
- Kanker Payudara18 studi
- Kolitis Ulseratif15 studi
- Mieloma Multipel13 studi
- Kanker Prostat11 studi
- Penyakit Crohn11 studi
- Kanker Kolorektal9 studi
- Kanker Metastatik9 studi
- Melanoma7 studi
- Kanker Ovarium7 studi
- Kanker Lambung6 studi
- Kanker Esofagus6 studi
- Kanker (semua jenis)6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.